Sarah Park et al. [26] investigated the mRNA levels of ABC transporter genes in breast cancer patients who underwent sequential weekly paclitaxel/FEC (5-fluorouracil, epirubicin and cyclophosphamide) neoadjuvant chemotherapy. The gene discussed is ABCG2; the disease is breast cancer.